Article
6-Desfluoroquinolones as HIV-1 Tat-Mediated Transcription Inhibitors
1 Jul 2010
Abstract excerpt
The current anti-HIV treatments fail to completely eradicate the virus in HIV-infected individuals, mainly as a result of a small pool of latently infected cells. This issue, together with the emergence of multidrug-resistant viruses, clearly highlights the need to find additional strategies. An overview of the Tat-mediated transcription inhibitors 6-desfluoroquinolones (6-DFQs), identified by our group, is given...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
